Clinical Trial Update: A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase I trial evaluating the relative bioavailability and food effect of HRS-1893 tablets in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy

Drugs mentioned

• HRS-1893

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Cardiomyopathy | Phase 1 | Status: COMPLETED